"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.
Synagis Patient Information including How Should I Take
In this Article
- What is palivizumab (Synagis)?
- What are the possible side effects of palivizumab (Synagis)?
- What is the most important information I should know about palivizumab (Synagis)?
- What should I discuss with my healthcare provider before receiving palivizumab (Synagis)?
- How is palivizumab given (Synagis)?
- What happens if I miss a dose (Synagis)?
- What happens if I overdose (Synagis)?
- What should I avoid while receiving palivizumab (Synagis)?
- What other drugs will affect palivizumab (Synagis)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving palivizumab (Synagis)?
Palivizumab should not be given to a child who has had a severe allergic reaction to it.
If your child has any of these other conditions, he or she may need a dose adjustment or special tests to safely use this medication:
- a bleeding or blood clotting disorder; or
- a low level of platelets in the blood.
It is not known whether palivizumab is harmful to use while pregnant or breast-feeding. Although this medication is generally not used in adults, a woman of child-bearing age who is treated with palivizumab should tell her doctor if she is pregnant or breast-feeding.
How is palivizumab given (Synagis)?
Palivizumab is given once a month during the RSV season, which is usually November through April but may be different where you live. Your child's doctor will tell you when the medication should be given.
Palivizumab is given as an injection into a muscle. A doctor, nurse, or other healthcare provider will give this injection. You may be shown how to use the medicine at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles and syringes.
Each single-use vial (bottle) of this medicine is for one use only. Throw away after one use, even if there is still some medicine left in it after injecting your dose.
Use each disposable needle only one time. Throw away used needles in a puncture-proof container (ask your pharmacist where you can get one and how to dispose of it). Keep this container out of the reach of children and pets.
Do not shake the medication bottle or you may ruin the medicine. Prepare your dose in a syringe only when you are ready to give yourself an injection. Do not use the medication if it has changed colors or has particles in it. Call your doctor for a new prescription.
This medication can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using palivizumab.
If you keep this medication at home, store it in the refrigerator. Do not freeze. Do not use the medication if the expiration date on the label has passed.
Additional Synagis Information
Synagis - User Reviews
Synagis User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.